We report a 21-year-old man who experienced symptoms of colitis following autologous TBI-conditioned PBSC transplantation, which persisted despite conventional treatment. Abdominal echography showed a thickened, stratified wall of the cecum, of the right colon and of part of the transverse colon. Hyperbaric oxygen therapy (20 sessions of 100% oxygen inhalation at 2.5 bar for 120 min in a hyperbaric chamber) achieved a prompt clinical recovery as well as complete disappearance of the ultrasound abnormalities. Keywords: colitis; hyperbaric oxygen therapy; TBI; PBSC Hyperbaric oxygen therapy is actually used as primary treatment of severe carbon monoxide poisoning, arterial gas embolism and decompression sickness and as adjuvant therapy for several diseases, including radiation-induced soft tissue injury.
Hyperbaric oxygen therapy is actually used as primary treatment of severe carbon monoxide poisoning, arterial gas embolism and decompression sickness and as adjuvant therapy for several diseases, including radiation-induced soft tissue injury. 1 Moreover, beneficial effects of hyperbaric oxygen therapy have been recently reported in radiationinduced intestinal damage.
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Case report
A 21-year-old man with high-grade non-Hodgkin's lymphoma of the neck (stage II A) achieved complete remission following first-line treatment (ProME(Epi)CECytaBOM + radiotherapy) (40 Gy to the right cervical and supraclavicular lymph nodes). Three months after treatment stopped, he relapsed with multiple nodes in the left neck, abdominal lymph nodes and spleen. Thus he received further radiotherapy, 40 Gy to the left cervical nodes plus four courses of high-dose cytotoxic drugs (1, Cy 7 g/m At day +82 he developed bloody diarrhoea with mucous, mild abdominal pain and anorexia. There were no abnormal physical signs and the patient was not taking oral nonabsorbable antibiotics. Stool examination for pathogens, including C. difficile, was negative. There was no evidence of CMV antigenemia. An ultrasound examination of the abdomen showed increased fluid content in the small bowel, whereas the cecum, right colon and a part of the transverse colon showed a thickened, stratified wall ( Figure 1) . Diarrhoea persisted, despite dietary restriction and cholestyramine treatment, and the ultrasound was unchanged. Endoscopy was refused by the patient. Colitis, secondary to chemo-radiotherapy, was suspected and hyperbaric oxygen therapy was planned. He received 20 sessions of 100% inhalation at 2.5 bar for 120 min in a hyperbaric chamber. The treatments being given daily (5 days/week, Monday to Friday) for a total of 4 weeks. By the time treatment was completed, the patient was asymptomatic and ultrasound examination showed the normal features of the right and transverse colon wall, while the cecal wall was unchanged. Three weeks later, echographic examination showed normal intestinal wall features (Figure 2 ). He remains free from lymphoma progression, with a good performance score (Karnofsky score: 100%), 18 months following autologous PBSC transplantation.
Discussion
Hyperbaric oxygen therapy has been used in a wide variety of diseases, with differing results. Recently, a better understanding of the cellular and biochemical effects has allowed definition of guidelines for the indications for hyperbaric oxygen treatment. 1 Hyperbaric oxygen treatment has been successfully used for radiation injuries, such as osteoradionecrosis and radiation myelitis. 4 We used hyperbaric oxygen therapy for our patient on the basis of two recent case reports suggesting a benefit for radiation-induced intestinal damage, 2,3 neither of which were in the setting of stem cell transplantation. The postulated mechanism of the effect of hyperbaric oxygen on irradiated tissues, where capacity for restorative cellular proliferation is impaired, is the induction of neovascularisation leading to an increased local oxygen tension. 2 The patient promptly recovered, and the ultrasonography normalized.
Hyperbaric oxygen, if administered according to current protocols, is safe. Adverse effects may rarely occur: damage of the middle-ear due to rapid pressure change, respiratory tract symptoms (chest pain, cough) and seizures. 1 Nevertheless, the cost of a cycle (20-40 sessions) of hyperbaric oxygen therapy should be compared with conventional, in-hospital treatment.
The good response in this patient should encourage clinical trials of hyperbaric oxygen therapy in patients who have undergone hematopoietic stem cell transplantation, with subsequent symptoms of mucosal damage sequelae (ie radiation enteritis following TBI).
